Ask AI
ProCE Banner Activity

Redefining Myeloma Care: An Expert Roundtable on the Potential of Novel Strategies Across the Disease Spectrum

Slideset

Download these slides from a recent educational program on novel emerging strategies to improve the management of patients with multiple myeloma.

Released: May 11, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb

Target Audience

This activity is intended for hematologists, oncologists, and other healthcare professionals who care for patients with multiple myeloma.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the mechanistic and clinical rationales for combining novel agents with proteasome inhibitors, anti-BCMA T-cell engagers, and other standard antimyeloma therapies

  • Identify patients with multiple myeloma who are likely to benefit from novel agent-based therapies under clinical trial investigation

  • Assess how emerging data for novel agent-based regimens could impact near-future treatment options for patients with newly diagnosed through heavily pretreated multiple myeloma